Spark Therapeutics, Inc.
Records under this name other than the patents Spark Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to Spark Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,551,970 | Genetic Suppression and Replacement Term ended Ended no later than Apr 2, 2017 · Low confidence | Term ended | Ended no later than Apr 2, 2017 | Low confidence |
| 10/000,773 | Suppression of polymorphic alleles Abandoned Abandoned Aug 18, 2008 | Abandoned | Abandoned Aug 18, 2008 | |
| 10/651,754 | Genetic suppression and replacement Abandoned Abandoned Mar 9, 2010 | Abandoned | Abandoned Mar 9, 2010 | |
| 10/742,656 | Suppression effectors that target non-coding regions and uses therefore Abandoned Abandoned Oct 12, 2007 | Abandoned | Abandoned Oct 12, 2007 | |
| 11/224,524 | Genetic suppression and replacement Abandoned Abandoned Aug 18, 2008 | Abandoned | Abandoned Aug 18, 2008 | |
| 12/188,304 | Allele Suppression Abandoned Abandoned Jan 3, 2011 | Abandoned | Abandoned Jan 3, 2011 | |
| 12/188,405 | Suppression of Polymorphic Alleles Abandoned Abandoned Jan 4, 2010 | Abandoned | Abandoned Jan 4, 2010 | |
| 15/143,272 | Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease Abandoned Abandoned Nov 14, 2018 | Abandoned | Abandoned Nov 14, 2018 | |
| 15/733,246 | Adeno-Associated Virus (AAV) Vector Lipid Nanoparticle Compositions and Methods of Use Abandoned Abandoned Dec 19, 2025 | Abandoned | Abandoned Dec 19, 2025 | |
| 15/772,025 | CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS Abandoned Abandoned Dec 28, 2024 | Abandoned | Abandoned Dec 28, 2024 |